The Academy at BioNJ is Proud to Partner with BioMentorz

 Click here to view all current course offerings by The Academy at BioNJ.

Biomentorz Logo

Doing Deals, Funding & More

Date to be announced shortly!

During this workshop experience, the BioMentorz team will expose participants to the practical knowledge the workshop leaders have accomplished and built over 65 years of CEO/CBO/BD assignments in the U.S. and internationally. This is a grounds-up, hands-on, real-world exposure to a process and best practices presented in an entertaining and interactive manner among participant peers and professionals.

The full, two-day program will cover a multitude of essential topics. Participants can elect to attend one day or both days of the program. Topics include:

  • VC Campaign Creation
  • Partnering Campaigns
  • Building a Company-Wide Team
  • Pitches
  • Presentations
  • Collateral Materials
  • Leveraging Industry and Scientific Meetings
  • Board Management
  • Communications
  • Tracking


  • 10 Partnering Do’s and Don’ts
  • Valuation
  • Selling Techniques
  • Getting Too Close
  • Term Sheets
  • Negotiations
  • Attorneys
  • The Day After
  • War Stories and More!


[/row]

Additionally, we will be addressing topics and issues that participants have from the very start of the workshop. You will not sit un-involved! Enrollment is limited so don’t hesitate!

Speaker Information

Jack Anthony is the founder of BioMentorz and has a wealth of experience with over 44 years in the healthcare industry. He is currently active with two VC firms, the acting CEO of Fibralign and formerly the CEO of Osprey Pharmaceuticals USA and CEO of Pharmix (now Numerate) and served as a member of the Board of Directors of Vaxgen. Prior to his CEO roles Jack focused for 15+ years on biotech business development and marketing at a variety of biotech companies.

Phil Haworth has 30 years of experience in the biotechnology industry as a research scientist, business development executive and private and public company CEO. Phil has led high performing research teams, business development groups and entire companies. He has executed significant licensing transactions on three continents and successfully raised money in extremely challenging environments in both the United States and the United Kingdom.

 You can read their full bios here.